Skip to main content
Journal of Medical Microbiology logoLink to Journal of Medical Microbiology
. 2020 Jan 14;69(3):487–491. doi: 10.1099/jmm.0.001136

Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens

Claire Jenkins 1,*, Neil T Perry 1, Gauri Godbole 1, Saheer Gharbia 1
PMCID: PMC7431092  PMID: 31935188

Abstract

Shiga toxin-producing Escherichia coli (STEC) are zoonotic pathogens that cause symptoms of severe gastrointestinal disease, including haemolytic uraemic syndrome (HUS), in humans. Currently in England, STEC serotypes other than O157:H7 are not cultured at the local hospital laboratories. The aim of this study was to evaluate the utility of CHROMagar STEC for the direct detection of STEC from faecal specimens in a diagnostic setting, compared to the current reference laboratory method using PCR targeting the Shiga-toxin gene (stx) to test multiple colonies cultured on MacConkey agar. Of the 292 consecutive faecal specimens submitted to the Gastrointestinal Bacterial Reference Unit that tested positive for stx by PCR, STEC could not be cultured on MacConkey agar or CHROMagar STEC from 87/292 (29.8 %). Of the 205 that were cultured, 106 (51.7 %) were detected on both MacConkey agar and CHROMagar STEC and 99 (48.3 %) were detected on MacConkey agar only. All 106 (100 %) isolates that grew on CHROMagar STEC had the ter gene cassette, known to be associated with resistance to tellurite, compared to 13/99 (13.1 %) that were not detected on CHROMagar STEC. CHROMagar STEC supported the growth of 36/40 (90 %) isolates harbouring stx2a or stx2d, the subtypes most frequently associated with progression to HUS. Of the 92 isolates harbouring eae, an important STEC virulence marker, 77 (83.7 %) grew on CHROMagar STEC. CHROMagar STEC is a useful selective media for the rapid, near-patient detection of STEC that have the potential to cause HUS.

Keywords: Shiga toxin-producing Escherichia coli, chromogenic selective agar, faecal specimens

Introduction

Shiga toxin-producing Escherichia coli (STEC) are zoonotic pathogens that cause symptoms of gastrointestinal (GI) disease in humans, including diarrhoea, bloody diarrhoea, abdominal pain and nausea. A sub-set of patients develop haemolytic ureamic syndrome (HUS), which is a severe condition associated with renal, neurological and/or cardiac complications, and can be fatal [1]. The STEC group is characterized by the presence of genes encoding Shiga toxin (Stx), stx1, stx2 or both. There are ten Stx subtypes, 1a, 1 c and 1d, and 2a-2g. STEC harbouring stx2a and stx2d alone or in combination with other stx subtype genes, are significantly associated with HUS [2–4]. STEC associated with more severe GI symptoms also have the intimin (eae for E. coli attaching and effacing) gene, located on a pathogenicity island called the locus of enterocyte effacement (LEE), and associated with the intimate attachment of the bacteria to the human gut mucosa [5].

In England, standard microbiology investigation protocols for the detection of STEC focus on the isolation of STEC serotype O157:H7 on selective media of non-sorbitol fermenting (NSF) colonies (http://www.hpa.org.uk/ProductsServices/MicrobiologyPathology/UKStandardsForMicrobiologyInvestigations/TermsOfUseForSMIs/AccessToUKSMIs/SMIBacteriology/smiB30InvestigationofFaecalSpecimensforEnteric/). Since 2013 an increasing number of local hospital laboratories in England have implemented commercial PCR assays targeting GI pathogens, including all STEC serotypes, as a first-line diagnostic detection method [6]. In England, faecal specimens from patients with symptoms of HUS and/or that are PCR positive for STEC but culture negative for STEC O157:H7, may be referred to the Gastrointestinal Bacterial Reference Unit (GBRU) at Public Health England for culture of non-O157 STEC. Current protocols for the detection of STEC other than serotype O157:H7 (non-O157 STEC) are technically demanding and labour intensive [6, 7].

In recent years, a range for different chromogenic media, containing a combination of inhibitors, metabolic substrates and dyes, have been developed with the aim to improve the culture of non-O157 STEC [8–11]. Inhibitors prevent the growth of Gram-positive bacteria, and STEC and other Enterobacteriaceae are differentiated by the colour of their colonies, resulting from the production of different metabolic by-products and their reaction with the dyes in the media. The implementation of selective agar for the detection of non-O157 STEC would facilitate rapid, near-patient testing at the local level, and improve the efficiency and cost effectiveness of the workflow at the reference laboratory. The aim of this study was to evaluate the utility of CHROMagar STEC for the direct detection of STEC from faecal specimens in a diagnostic setting, compared to the current reference laboratory method using PCR targeting the Shiga-toxin gene (stx) to test multiple colonies cultured on MacConkey agar.

Methods

Faecal specimens submitted to local hospital diagnostic laboratories from hospitalized patients, and community cases reporting to their general practitioner with symptoms of GI disease were included in this study. All faecal specimens submitted to GBRU between April and June 2019 were inoculated onto MacConkey agar and into tryptone soya broth (TSB), and incubated at 37 °C, as per the standard protocol [7]. For the purposes of this evaluation, faecal specimens were also cultured onto CHROMagar STEC, and incubated at 37 °C. STEC appear as mauve-coloured colonies on CHROMagar STEC and can be differentiated from other Enterobacteriaceae and other Gram-negative bacteria that appear as blue and colourless colonies, respectively.

Following overnight incubation, DNA was extracted from TSB using Instagene (Bio-Rad Catalog No. 732–6030) and tested using the EU-RL VTEC real-time PCR primers and probes detecting stx1, stx2, eae (intimin) and O157rfbE (http://www.iss.it/binary/vtec/cont/VTEC_RealTime.pdf) on a Rotorgene Q (Qiagen, UK) as described previously [7]. For all faecal specimens that tested positive for stx, ten colonies were selected from the MacConkey agar and retested using the same PCR. Ten colonies were picked from the MacConkey agar because the agar is not non-selective for STEC, and PCR of ten colonies is required to maximize the chance of identifying the stx-positive colonies. In contrast, because CHROMagar STEC agar is selective for STEC, a single mauve colony was retested using the same PCR.

Those colonies harbouring the stx genes were sequenced, and serotype, stx profile, and the presence of eae and the ter gene cluster were determined from the WGS data, as described previously [12]. Briefly, genomic DNA was extracted, fragmented and tagged for multiplexing with Nextera XT DNA Sample Preparation Kits (Illumina) and sequenced using the Illumina HiSeq 2500. The reference databases, SerotypeFinder and Virulencefinder, containing the gene sequences encoding the O and H antigen groups, eae and the ter gene cluster were constructed as described by Joensen et al., [13]. Using the GeneFinder tool (Doumith unpublished), fastq reads were mapped to the genes in the reference databases using Bowtie 2 [14]. Stx subtyping was performed as described by Ashton et al., [15].

Comparisons were made with the presence and absence of eae in STEC and the presence of the ter gene cluster, and the ability to grow on CHROMagar STEC. A chi-squared test was used to assess statistical significance. A P-value of <=0.05 was deemed statistically significant. All statistical analyses were performed using stata 12.0 (Stata Corporation).

Results

During the time frame of the study, 292 faecal specimens tested positive for stx by PCR. STEC could not be cultured on MacConkey or CHROMagar STEC from 87/292 (29.8 %) consecutive faecal specimens submitted to GBRU. Of the 205 isolates that were cultured, 106 (51.7 %) were recovered from both MacConkey agar using the ‘ten-colony’ method described above and CHROMagar STEC and 99 (48.3 %) were detected on MacConkey agar only. Characteristics of the isolates of STEC cultured on both MacConkey agar and CHROMagar STEC, and those cultured on MacConkey agar alone, including serotype, stx profile and the presence or absence of eae and the ter gene cassette encoding resistance to tellurite, were compared.

Of the 106 isolates that were successfully cultured using both methods, 20 different serotypes were identified, and there were 36 different serotypes identified in the 99 isolates that were cultured using the current method (Tables 1 and 2). The most common non-O157 STEC serotypes that were cultured on CHROMagar STEC were O26:H11 (n=35/106, 33.0 %) and O146:H21 (n=18/106, 17.0 %). Of the STEC serotypes that could not be cultured on CHROMagar STEC, the most common were O91:H14 (n=21/99, 21.2 %) and O128ab:H2 (n=11/99, 11.1 %).

Table 1.

stx subtypes, presence of eae and serotype of STEC that were cultured on CHROMagar

Stx subtype

No. (n=106)

Serotype

Stx1c

10

O146:H21 (8); O153-O178:H7 (2)

Stx1a+eae

31

O26:H11 (18); O103:H2 (3); O103:H8; O123:H2 (3); O71:H2 (2); O111:H8; O151:H2; O156:H25; O182:H25

Stx1c+stx2b

10

O146:H21 (9); O166:H28

Stx1a+stx2 a+eae

7

O26:H11 (5); O111:H8; O71:H8

Stx2b

11

O146:H21 (1); O146:H28 (8); O27:H30; O166:H28

Stx2a+eae

15

O26:H11 (10); O145:H28 (5)

Stx2c+eae

2

O26:H11 (2)

Stx2a+stx2 c+eae

1

O177:H25

Stxd +eae

1

O80:H2

Stx1a+stx2 c+eae+O157

2

O157:H7 (2)

Stx2c+eae+O157

10

O157:H7 (10)

Stx2a+eae+O157

1

O157:H7

Stx2a+stx2 c+eae+O157

5

O157:H7 (5)

Table 2.

stx subtypes, presence of eae and serotype of STEC that could not be detected on CHROMagar

Stx subtype

No. (n=99)

Serotype

Stx1a

8

O91:H14 (3); O117:H7 (4); O152:H8

Stx1c

20

O78:H4 (4); O81:H21 (2); O126:H8 (2); O76:H19 (6); O128ab:H2; O146:H21; O43:H2; O38:H26 (2); O153-O178:H7

Stx1a+eae

8

O84:H4 (2); O111:H8 (2); O103:H2 (1); O103:H2 (2); O108:H25

Stx1a+stx2b

13

O91:H14 (13)

Stx1c+stx2b

19

O76:H19 (2); O128ab:H2 (6); O113:H4 (4); O112:H2; O38:H26 (2); O81:H21; O102:H6; O166:H28; O123:H10

Stx1a+stx2 c+eae

1

O71:H8

Stx1a+stx2 a+eae

4

O26:H11 (2): O165:H25 (2)

Stx2b

17

O91:H14 (5); O128ab:H2 (4); O?:H45 (3); O?:H8; O87:H16; O146:H21; O166:H28 (2)

Stx2c

1

O142:H16

Stx2a

2

O8:H19; O178:H19;

Stx2a+eae

1

O145:H28

Stx2d

2

O113:H4; O113:H21

Stx2d+eae

1

O145:H25

Stx2g

2

O2:H25; O?:H7

Serotypes highlighted in bold had the ter gene cluster; they were not detected from the faecal specimen when inoculated directly on to CHROMagar but grew within 24 h on CHROMagar when inoculated from the subculture that was detected using the MacConkey agar using the ten-colony method.

All 106 (100 %) isolates that were isolated on CHROMagar STEC had the ter gene cassette, known to be associated with resistance to tellurite [16, 17]. Of those isolates that were not detected on CHROMagar STEC, 13/99 (13.1 %) had the ter gene cassette. All 13 STEC isolates that had the ter gene cassette but were not detected from the faecal specimen when inoculated directly on to CHROMagar STEC, grew within 24 h on CHROMagar STEC when inoculated from the subculture that was detected using the MacConkey agar using the ‘ten-colony’ method (Table 2). This indicated that the failure to detect these isolates on CHROMagar STEC was caused by overgrowth of competing commensal bacteria, rather than inhibition on the selective agar.

The number of isolates testing positive for eae that were cultured using both methods (CHROMagar STEC and MacConkey ten-colony method) and the current MacConkey ‘ten-colony’ method only, was 77/106 (72.6 %) and 15/99 (15.2 %), respectively. Among 92 eae-positive STEC strains, 88 (95.7 %) harboured the intact ter gene cluster and were tellurite resistant. In comparison, 41/114 (36.0 %) eae-negative isolates had the ter gene cluster. In this study, the presence of eae in STEC was significantly associated with the presence of the ter gene cluster (P=0.001) and the ability to grow on CHROMagar STEC (P=0.001). Therefore, CHROMagar STEC supported the growth of 77/92 (83.7 %) isolates harbouring eae.

The most common stx/eae profiles exhibited by the isolates that were cultured on CHROMagar STEC were stx1a+eae (n=21/106, 19.8 %), and stx2a+eae (n=15/106, 14.2 %). Of the stx profiles exhibited by the isolates that could not be cultured on CHROMagar STEC, the most common were stx1c (n=20/99, 20.2 %) stx1c+stx2 b (n=19/99, 19.2 %) and stx2b (n=17/99, 17.2 %). Of the isolates that grew on CHROMagar STEC 30/106 (28.3 %) had stx2a compared to 10/99 (10.1 %) that failed to grow on CHROMagar STEC. Of the ten that failed to grow, six had the ter gene cassette, and grew on CHROMagar STEC following sub-culture. Therefore, CHROMagar STEC supported the growth of 36/40 (90 %) isolates harbouring stx2a or stx2d.

Discussion

Previous studies evaluating CHROMagar STEC have focused on the non-O157 serogroups most likely to cause severe symptoms, STEC O26, O103, O111, O121, O145 and O45, referred to in the literature as the ‘top six’; while others have included a wider range of STEC serogroups [8–11, 17, 18]. With the exception of Wylie et al. [9], these studies have used sub-cultured archived collections of isolates of non-O157, rather than culturing directly from faecal specimens. In contrast, the purpose of the study described in this report was to evaluate the utility of CHROMagar STEC for the detection of non-O157 STEC serotypes in a real-time diagnostic setting.

No STEC was cultured using either method for 29.8 % of the specimens tested. PCR is a more sensitive test than culture, and the most likely explanation for failure to culture is that the bacterial load in the specimen was below the detection limit of either of the culture methods used [7]. In addition, competing commensal bacteria and various inhibiting factors, that are normally present in faecal specimens, could impact on the failure to recover STEC in these samples. Of the STEC cultured from consecutive faecal specimens that tested positive for stx submitted to GBRU during the study period, 51.7 % were recovered using CHROMagar STEC. Using the same chromogenic agar, recovery rates for the detection of STEC O157 and the top six non-O157 STEC serogroups reported by Hirvonen et al. and Wylie et al. were 74.3 and 86.5 %, respectively [8, 9]. Studies where a more diverse range of STEC serogroups were selected with the purposes of constructing a more challenging strain set report a lower recovery rate. In the study by Kalule et al. CHROMagar STEC agar supported the growth of less than half the strains tested (46.8%) [17].

All 106 isolates of STEC that grew on CHROMagar STEC had the ter gene cassette, which in STEC O157:H7 comprises eight genes terZ, terA, terB, terC, terD, terE, terF and terW [19, 20]. Correlation of growth of STEC on CHROMagar STEC with the presence of the ter gene cassette encoding resistance to tellurite is well documented in the literature [8–11, 17, 18]. Successful detection of STEC in a complex background requires an agar medium that suppresses the growth of background micro-organisms with minimal suppression of target STECs. Potassium tellurite has been added to agar media to facilitate the isolation of STEC O157:H7 since the mid-1990s, with resistance to tellurite being the primary principle of the selective medium [21]. The ter genes are commonly present in clinically relevant STEC isolates, including STEC O157:H7. However, some clinically relevant non-O157 STEC serogroups, such as O91 and O113, cannot grow on standard media containing 2.5 µg ml−1 of potassium tellurite [16, 22].

Explanations as to why the STEC isolates harbouring the ter gene cluster were missed on primary culture included: (i) heavy growth of other tellurite-resistant bacteria masking the presence of the mauve STEC colonies and (ii) more than one strain of bacteria growing as mauve colonies on the agar plate and an stx-negative colony being selected for re-PCR. Furthermore, non-O157 STEC strains displayed mauve colouring with many shades on CHROMagar STEC agar, as described previously [23]. The mauve colour ranges from purple through to mauve to grey, and those colonies at the grey end of the spectrum may be more easily missed on the primary culture plate.

CHROMagar STEC was developed to facilitate the detection of the serotypes of STEC most commonly associated with severe GI disease, including HUS. Data from 2017, shows that the most common STEC serotypes causing severe GI disease in the UK are STEC O157:H7 and O26:H11 and both serotypes can be cultured on CHROMagar STEC [1, 6, 12]. Moreover, in this study, 75 % of STEC harbouring stx2a or stx2d, the stx subtypes associated with more severe GI symptoms, were detected using the CHROMagar STEC, 90 % including those that were resistant to tellurite but were missed on primary culture. The eae gene is a marker for virulence linked to human disease and may be beneficial to survival of the organism in the food chain [16]. In this study, the presence of eae in STEC was significantly associated with the presence of the ter cluster (P=0.001), and therefore the ability of STEC to grow on CHROMagar STEC [24]. The results from this study showed that the majority of STEC exhibiting the potential to cause severe gastrointestinal symptoms, specifically those harbouring stx2a or stx2d (36/40, 90%) and eae [77/92 (83.7 %)], were detected using CHROMagar STEC.

Regardless of whether the diagnostic microbiology laboratory has implemented PCR for the detection of STEC (and other GI pathogens), the addition of CHROMagar STEC to the standard microbiological investigation protocols for faecal specimen will improve the detection of non-O157 STEC. Selected colonies identified on CHROMagar STEC can be sent to the reference laboratory for confirmation of STEC and typing. For laboratories that have implemented PCR, use of CHROMagar STEC will enable them to culture non-O157 STEC directly from the faecal specimens testing positive for stx. Non-O157 STEC is becoming an increasingly serious public health concern in the UK [6, 12, 25]. Robust and reliable detection of non-O157 STEC will enhance surveillance activities, facilitate outbreak detection and investigation, and improve the diagnosis of STEC-HUS.

Funding information

The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with University of Warwick. Claire Jenkins is based at Public Health England. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.

Acknowledgements

We would like to thank Francesco Tripodo, Amina Ismail and Michael Wright for assisting with the implementation of the new media in GBRU, Saira Butt and Tim Dallman for help with the statistical analysis, and Andrew Fox and Derren Ready for reviewing the manuscript.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Ethical statement

The authors declare that there is no requirement for ethical approval for this submission. This work was undertaken to inform the delivery of patient care and to prevent the spread of infection, defined as USUAL PRACTICE in public health and health protection.

Footnotes

Abbreviations: eae, E. coli attaching and effacing; GBRU, Gastrointestinal Bacterial Reference Unit; HUS, haemolytic uraemic syndrome; LEE, Locus of Enterocyte Effacement; STEC, Shiga toxin-producing Escherichia coli; stx, Shiga toxin.

References

  • 1.Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009–2012. Epidemiol Infect. 2015;143:3475–3487. doi: 10.1017/S0950268815000746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ethelberg S, Olsen KEP, Scheutz F, Jensen C, Schiellerup P, et al. Virulence factors for hemolytic uremic syndrome, Denmark1. Emerg Infect Dis. 2004;10:842–847. doi: 10.3201/eid1005.030576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Persson S, Olsen KEP, Ethelberg S, Scheutz F. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol. 2007;45:2020–2024. doi: 10.1128/JCM.02591-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Luna-Gierke RE, Wymore K, Sadlowski J, Clogher P, Gierke RW, et al. Multiple-aetiology enteric infections Involving Non-O157 Shiga Toxin-Producing Escherichia coli - FoodNet, 2001-2010. Zoonoses Public Health. 2014;61:492–498. doi: 10.1111/zph.12098. [DOI] [PubMed] [Google Scholar]
  • 5.Stevens MP, Frankel GM. The locus of enterocyte effacement and associated virulence factors of enterohemorrhagic Escherichia coli . Microbiol Spectr. 2014;2:EHEC-0007–-2013. doi: 10.1128/microbiolspec.EHEC-0007-2013. [DOI] [PubMed] [Google Scholar]
  • 6.Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK, et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. J Med Microbiol. 2014;63:1181–1188. doi: 10.1099/jmm.0.075895-0. [DOI] [PubMed] [Google Scholar]
  • 7.Jenkins C, Lawson AJ, Cheasty T, Willshaw GA. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli . J Med Microbiol. 2012;61:1082–1085. doi: 10.1099/jmm.0.041517-0. [DOI] [PubMed] [Google Scholar]
  • 8.Hirvonen JJ, Siitonen A, Kaukoranta S-S. Usability and performance of CHROMagar STEC medium in detection of Shiga toxin-producing Escherichia coli strains. J Clin Microbiol. 2012;50:3586–3590. doi: 10.1128/JCM.01754-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wylie JL, Van Caeseele P, Gilmour MW, Sitter D, Guttek C, et al. Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada. J Clin Microbiol. 2013;51:466–471. doi: 10.1128/JCM.02329-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gill A, Huszczynski G, Gauthier M, Blais B. Evaluation of eight agar media for the isolation of Shiga toxin—producing Escherichia coli . J Microbiol Methods. 2014;96:6–11. doi: 10.1016/j.mimet.2013.10.022. [DOI] [PubMed] [Google Scholar]
  • 11.Verhaegen B, De Reu K, Heyndrickx M, De Zutter L. Comparison of six chromogenic agar media for the isolation of a broad variety of non-O157 Shigatoxin-producing Escherichia coli (STEC) serogroups. Int J Environ Res Public Health. 2015;12:6965–6978. doi: 10.3390/ijerph120606965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chattaway MA, Dallman TJ, Gentle A, Wright MJ, Long SE, et al. Whole genome sequencing for public health surveillance of Shiga toxin-producing Escherichia coli other than serogroup O157. Front Microbiol. 2016;7:258. doi: 10.3389/fmicb.2016.00258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, et al. Real-Time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli . J Clin Microbiol. 2014;52:1501–1510. doi: 10.1128/JCM.03617-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ashton PM, Perry N, Ellis R, Petrovska L, Wain J, et al. Insight into Shiga toxin genes encoded by Escherichia coli O157 from whole genome sequencing. PeerJ. 2015;3:e739. doi: 10.7717/peerj.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Orth D, Grif K, Dierich MP, Würzner R. Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol. 2007;158:105–111. doi: 10.1016/j.resmic.2006.10.007. [DOI] [PubMed] [Google Scholar]
  • 17.Kalule JB, Keddy KH, Smith A, Nicol MP, Robberts L. Development of a real-time PCR assay and comparison to CHROMagar STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa. Afr. J. Lab. Med. 2017;6:609. doi: 10.4102/ajlm.v6i1.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kalule JB, Keddy KH, Nicol MP. Characterisation of STEC and other diarrheic E. coli isolated on CHROMagar STEC at a tertiary referral hospital, Cape Town. BMC Microbiol. 2018;18:55. doi: 10.1186/s12866-018-1195-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Taylor DE. Bacterial tellurite resistance. Trends Microbiol. 1999;7:111–115. doi: 10.1016/S0966-842X(99)01454-7. [DOI] [PubMed] [Google Scholar]
  • 20.Bielaszewska M, Tarr PI, Karch H, Zhang W, Mathys W, et al. Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm. J Clin Microbiol. 2015;53:1588–1598. doi: 10.1128/JCM.03590-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chapman PA, Wright DJ, Siddons CA. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli 0157 from bovine faeces. J Med Microbiol. 1994;40:424–427. doi: 10.1099/00222615-40-6-424. [DOI] [PubMed] [Google Scholar]
  • 22.Kerangart S, Douëllou T, Delannoy S, Fach P, Beutin L, et al. Variable tellurite resistance profiles of clinically-relevant Shiga toxin-producing Escherichia coli (STEC) influence their recovery from foodstuffs. Food Microbiol. 2016;59:32–42. doi: 10.1016/j.fm.2016.05.005. [DOI] [PubMed] [Google Scholar]
  • 23.Stromberg ZR, Lewis GL, Moxley RA. Comparison of agar media for detection and quantification of Shiga toxin–producing Escherichia coli in cattle feces. J Food Prot. 2016;79:939–949. doi: 10.4315/0362-028X.JFP-15-552. [DOI] [PubMed] [Google Scholar]
  • 24.Turkovicova L, Smidak R, Jung G, Turna J, Lubec G, et al. Proteomic analysis of the TERC interactome: novel links to tellurite resistance and pathogenicity. J Proteomics. 2016;136:167–173. doi: 10.1016/j.jprot.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 25.Carroll KJ, Harvey-Vince L, Jenkins C, Mohan K, Balasegaram S. The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013–March 2017 and significance for clinical and public health. J Med Microbiol. 2019;68:930–939. doi: 10.1099/jmm.0.000970. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Microbiology are provided here courtesy of Microbiology Society

RESOURCES